APA (7th ed.) Citation

AL, P., R, B., CJ, L., I, P., M, L., CA, K., & JS, P. (2025). Improved HbA1c and Body Weight in GADA-Positive Individuals Treated With Tirzepatide: A Post Hoc Analysis of SURPASS. The Journal of clinical endocrinology and metabolism, 110(4), e962. https://doi.org/10.1210/clinem/dgae372

Chicago Style (17th ed.) Citation

AL, Peters, Buzzetti R, Lee CJ, Pavo I, Liu M, Karanikas CA, and Paik JS. "Improved HbA1c and Body Weight in GADA-Positive Individuals Treated With Tirzepatide: A Post Hoc Analysis of SURPASS." The Journal of Clinical Endocrinology and Metabolism 110, no. 4 (2025): e962. https://doi.org/10.1210/clinem/dgae372.

MLA (9th ed.) Citation

AL, Peters, et al. "Improved HbA1c and Body Weight in GADA-Positive Individuals Treated With Tirzepatide: A Post Hoc Analysis of SURPASS." The Journal of Clinical Endocrinology and Metabolism, vol. 110, no. 4, 2025, p. e962, https://doi.org/10.1210/clinem/dgae372.